Bowel preparation for capsule endoscopy (CE) has not been standardized.
Similarly, treatment with the TCM preparation Tongxinluo capsule increased ZO-1 and occludin expression in cerebral microvessels 24 h after MCAO in mice.
All patients were vaccinated with Pneumo23, a preparation containing capsule polysaccharides of 23 pneumococcal serotypes (MSD, Brussels, Belgium), and Afluria, influenza vaccine (ZLB Pharma, Marburg, Germany), administered intramuscularly.
Nissl staining and DNA fragmentation assays demonstrated that the TCM preparation Naoshuantong capsule reduced neuronal apoptosis in ischemic cortex and in the hippocampal CA1 region after rat MCAO; neurological functional deficits were also attenuated.
For example, 2,3,5-triphenyltetrazolium chloride (TTC) staining showed that the TCM preparation Xuezhikang capsule, total flavones of Chinese materia medica Huangshukui (Abelmoschus manihot), and active compounds, such as calycosin and astrogaloside, inhibited brain infarction mainly by anti-oxidative effect.
In our study, a 'one-stop shop' process – using one colonic preparation for capsule endoscopy, followed by colonoscopy in case of lesions, requiring very rapid reading - was not attempted or done (and this was explained to patients during informed consent).
As for now, if preparation for capsule is more complex than for CSPY, with the procedure itself bearing a risk of volume overload especially in predisposed patients, how large is the benefit of CCE? Third, 8-10 hofrs of validated capsule battery duration were not sufficient for all patients, especially those with transit disorders.
It was reported that the TCM preparation Tongxinluo capsule increased the number of nestin-positive neurons and VEGF mRNA expression in the rat subventricular zone and hippocampal subdentate gyrus zone of the ischemic hemisphere after MCAO, indicating a capacity of promoting differentiation and proliferation of the neural stem cells 133, 134.
This antibody was generated by immunizing mice with the capsule preparation which subsequently resulted in the evolution of antibody 11B7.
This preparation is in capsule form, and is standardised to contain 5% gingerols.
